Pierre Fabre Italy’s Charles-Henri Bodin highlights how the French firm’s offering has expanded far beyond its dermo-cosmetics heritage to today encompass a wide range of pharmaceuticals, including the key growth area of oncology. Bodin also outlines the importance of Italy – one of PF’s first international affiliates – to the global group, and gives his thoughts on digitalisation, patient-centricity, and sustainability.
Even though we are a mid-sized company, and the competition is tough, we are working very hard to achieve success [in oncology]
